Kevin Heyeck

Form D signer

Kevin Heyeck

Chief Executive Officer at Chimeron Bio

Form D signer

Capital raised by Chimeron Bio

$12.8M+$12.8M latest round

1 Form D filing · first filed Mar 2024 · Philadelphia, PA

CURRENT ROLE: Chief Executive Officer
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: 2 ↗

Career

1 company on file

Chimeron BioBiotech · Philadelphia, PAsince Mar 2024

Chief Executive Officer

Signatory on Chimeron Bio's Form D filings · $12.8M raised across 1

Company filings

via EDGAR · Form D for Chimeron Bio1

DateCompanyFormAmountRole on filing

Mar 25, 2024Chimeron BioForm D/A+$12.8MChief Executive Officer

Form D/AMar 25, 2024 · Chimeron Bio+$12.8Mas Chief Executive Officer

Overview

Last filing Mar 25, 2024

Kevin Heyeck is on file as Chief Executive Officer at Chimeron Bio in Philadelphia, PA. Chimeron Bio has 1 Form D filing on record, $12.8M raised in total. Kevin Heyeck appears as a signatory on the company's filings.

Teammates

Chimeron Bio · 1

Afshin SafaviDirector

Products

Chimeron Bio · 1

ChaESAR™ PlatformBiotechnology Platform

The ChaESAR™ platform is a proprietary technology that employs self-amplifying RNA (saRNA) to develop potent RNA-based therapeutics and vaccines. This platform enhances the efficacy and longevity of treatment effects while reducing the necessary dosage and simplifying the production and distribution processes.